Revance Therapeutics (NQ: RVNC )

4.170 -0.140 (-3.25%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 15, 2024 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
May 10, 2018
Form 4
Source: SEC/Edgar
May 10, 2018
Form 4
Source: SEC/Edgar
May 10, 2018
Form 4
Source: SEC/Edgar
May 10, 2018
Form 3
Source: SEC/Edgar
May 02, 2018
Form 4
Source: SEC/Edgar
May 02, 2018
Form 4
Source: SEC/Edgar
March 15, 2018
Form 4
Source: SEC/Edgar
March 15, 2018
Form 4
Source: SEC/Edgar
March 15, 2018
Form 4
Source: SEC/Edgar
March 08, 2018
Form 4
Source: SEC/Edgar
March 08, 2018
Form 4
Source: SEC/Edgar
February 15, 2018
Form 4
Source: SEC/Edgar
February 15, 2018
Form 4
Source: SEC/Edgar
February 15, 2018
Form 4
Source: SEC/Edgar
February 08, 2018
Form 4
Source: SEC/Edgar
February 08, 2018
Form 4
Source: SEC/Edgar
February 08, 2018
Form 4
Source: SEC/Edgar
February 08, 2018
Form 4
Source: SEC/Edgar
January 29, 2018
Form 4
Source: SEC/Edgar
January 02, 2018
Form 4
Source: SEC/Edgar
January 02, 2018
Form 4
Source: SEC/Edgar
December 27, 2017
Form 4
Source: SEC/Edgar
December 17, 2017
Form 4
Source: SEC/Edgar
November 23, 2017
Form 4
Source: SEC/Edgar
October 19, 2017
Form 4
Source: SEC/Edgar
September 21, 2017
Form 3
Source: SEC/Edgar
September 19, 2017
Form 4
Source: SEC/Edgar
September 19, 2017
Form 4
Source: SEC/Edgar
September 06, 2017
Form 3
Source: SEC/Edgar
September 06, 2017
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.